{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:57:05Z","timestamp":1762887425749,"version":"3.45.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018719","name":"School of Medicine, University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","award":["2018280"],"award-info":[{"award-number":["2018280"]}],"id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ogla.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T13:25:10Z","timestamp":1655213110000},"page":"658-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-9432","authenticated-orcid":false,"given":"Haochen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3363-3707","authenticated-orcid":false,"given":"Jackson","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-8357","authenticated-orcid":false,"given":"Jella Angela","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2022.06.005_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ogla.2019.02.002","article-title":"Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes","volume":"2","author":"Sarrafpour","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2022.06.005_bib2","first-page":"94","article-title":"Micropulse transscleral cyclophotocoagulation: a hypothesis for the ideal parameters","volume":"7","author":"Sanchez","year":"2018","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.ogla.2022.06.005_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ogla.2020.02.005","article-title":"The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma","volume":"3","author":"Kaba","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"year":"2017","series-title":"Transcleral Laser Induces Aqueous Outflow Pathway Motion and Reorganization","author":"Johnstone","key":"10.1016\/j.ogla.2022.06.005_bib4"},{"key":"10.1016\/j.ogla.2022.06.005_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2022.06.005_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ajo.2019.03.002","article-title":"Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase 3 ROCKET-4 study","volume":"204","author":"Khouri","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2022.06.005_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ophtha.2014.08.022","article-title":"Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure","volume":"122","author":"Bacharach","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2022.06.005_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/IJG.0b013e3182952213","article-title":"Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes","volume":"24","author":"Wang","year":"2015","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2022.06.005_bib9","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1167\/iovs.16-20189","article-title":"Netarsudil increases outflow facility in human eyes through multiple mechanisms","volume":"57","author":"Ren","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2022.06.005_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00417-020-04691-y","article-title":"Dose-dependent effects of netarsudil, a rho-kinase inhibitor, on the distal outflow tract","volume":"258","author":"Chen","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ogla.2022.06.005_bib11","series-title":"Conference: Health Science Research","article-title":"Comparison of Response to Netarsudil in Kahook Dual Blade Goniotomy Treated Eyes Compared to Surgically-Na\u00efve Eyes","author":"Xu","year":"2019"},{"key":"10.1016\/j.ogla.2022.06.005_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ogla.2020.01.005","article-title":"Netarsudil\u2019s effect in eyes with a history of selective laser trabeculoplasty","volume":"3","author":"Lin","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2022.06.005_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jcjo.2021.02.040","article-title":"Relationship between selective laser trabeculoplasty and excisional goniotomy outcomes in glaucomatous eyes","volume":"57","author":"King","year":"2022","journal-title":"Can J Ophthalmol"},{"year":"2019","series-title":"Rhopressa\u00ae (netarsudil ophthalmic solution) 0.02% prescribing information","author":"Aerie","key":"10.1016\/j.ogla.2022.06.005_bib14"},{"key":"10.1016\/j.ogla.2022.06.005_bib16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","volume":"125","author":"Tanna","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2022.06.005_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ogla.2019.08.009","article-title":"Micropulse transscleral diode laser cyclophotocoagulation in refractory glaucoma: short-term efficacy, safety, and impact of surgical history on outcomes","volume":"2","author":"Garcia","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2022.06.005_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/IJG.0000000000001174","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients","volume":"28","author":"Zaarour","year":"2019","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2022.06.005_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajo.2019.06.016","article-title":"Netarsudil\/latanoprost fixed-dose combination for elevated intraocular pressure: three-month data from a randomized phase 3 trial","volume":"207","author":"Asrani","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2022.06.005_bib20","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/OPTH.S154001","article-title":"Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date","volume":"12","author":"Dasso","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ogla.2022.06.005_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","article-title":"Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: rho kinase elevated IOP treatment trial (ROCKET-2)","volume":"200","author":"Kahook","year":"2019","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419622000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419622000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:52:50Z","timestamp":1762887170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419622000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2589419622000989"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2022.06.005","relation":{},"ISSN":["2589-4196"],"issn-type":[{"type":"print","value":"2589-4196"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}